0001640334-23-001200.txt : 20230703 0001640334-23-001200.hdr.sgml : 20230703 20230703140513 ACCESSION NUMBER: 0001640334-23-001200 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230703 DATE AS OF CHANGE: 20230703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MATSUI CONNIE CENTRAL INDEX KEY: 0001236537 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38951 FILM NUMBER: 231064674 MAIL ADDRESS: STREET 1: 3030 CALLAN RD CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARTELO BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001621221 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 331220924 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 LOMAS SANTA FE, SUITE 160 CITY: SOLANA BEACH STATE: CA ZIP: 92075 BUSINESS PHONE: 858-925-7049 MAIL ADDRESS: STREET 1: 505 LOMAS SANTA FE, SUITE 160 CITY: SOLANA BEACH STATE: CA ZIP: 92075 FORMER COMPANY: FORMER CONFORMED NAME: REACTIVE MEDICAL INC. DATE OF NAME CHANGE: 20170207 FORMER COMPANY: FORMER CONFORMED NAME: KNIGHT KNOX DEVELOPMENT CORP. DATE OF NAME CHANGE: 20141001 4 1 form4.xml FORM 4 X0407 4 2023-06-30-05:00 false 0001621221 ARTELO BIOSCIENCES, INC. ARTL 0001236537 MATSUI CONNIE C/O ARTELO BIOSCIENCES, INC. 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075 true false false false false Stock Option (right to buy) 2.01 2023-06-30-05:00 4 A false 667 0.00 A 2033-06-30-05:00 Common Stock 667 667 D Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. "Vesting Commencement Date" shall mean June 30, 2023. /s/ Gregory D. Gorgas, as Attorney-in-Fact 2023-07-03-05:00